First National Bank of Omaha’s Integra LifeSciences IART Stock Holding History

First National Bank of Omaha’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35,445	Closed	-$1.46M	–	327
2023 Q2	$1.46M	Buy	35,445 +191	+0.5%	+$9.19K	0.08%	205
2023 Q1	$2.02M	Sell	35,254 -487	-1%	-$27.4K	0.12%	175
2022 Q4	$2M	Sell	35,741 -508	-1%	-$25.9K	0.12%	176
2022 Q3	$1.54M	Buy	36,249 +174	+0.5%	+$8.91K	0.1%	197
2022 Q2	$1.95M	Sell	36,075 -530	-1%	-$31.8K	0.12%	170
2022 Q1	$2.35M	Sell	36,605 -15,303	-29%	-$1.01M	0.12%	174
2021 Q4	$3.48M	Buy	51,908 +1,484	+3%	+$100K	0.17%	150
2021 Q3	$3.45M	Sell	50,424 -3,679	-7%	-$260K	0.18%	149
2021 Q2	$3.74M	Hold	54,103	–	–	0.2%	148
2021 Q1	$3.74M	Sell	54,103 -3,793	-7%	-$257K	0.2%	148
2020 Q4	$3.76M	Buy	57,896 +5,768	+11%	+$310K	0.2%	141
2020 Q3	$2.46M	Sell	52,128 -71	-0.1%	-$3.38K	0.15%	147
2020 Q2	$2.45M	Sell	52,199 -422	-0.8%	-$20.7K	0.16%	142
2020 Q1	$2.35M	Buy	52,621 +7,191	+16%	+$377K	0.18%	140
2019 Q4	$2.65M	Buy	45,430 +3,675	+9%	+$219K	0.16%	156
2019 Q3	$2.51M	Buy	41,755 +711	+2%	+$42.4K	0.16%	160
2019 Q2	$2.29M	Buy	41,044 +1,001	+2%	+$51.5K	0.15%	165
2019 Q1	$2.23M	Buy	40,043 +4,424	+12%	+$225K	0.15%	157
2018 Q4	$1.61M	Sell	35,619 -4,361	-11%	-$239K	0.12%	171
2018 Q3	$2.63M	Buy	39,980 +1,076	+3%	+$66.9K	0.15%	182
2018 Q2	$2.51M	Sell	38,904 -152	-0.4%	-$9.41K	0.15%	185
2018 Q1	$2.16M	Buy	39,056 +1,339	+4%	+$70.2K	0.13%	194
2017 Q4	$1.8M	Buy	37,717 +5,065	+16%	+$248K	0.11%	219
2017 Q3	$1.65M	Buy	32,652 +585	+2%	+$30K	0.1%	219
2017 Q2	$1.75M	Sell	32,067 -6,420	-17%	-$307K	0.11%	210
2017 Q1	$1.62M	Buy	38,487 +8,255	+27%	+$353K	0.1%	222
2016 Q4	$1.3M	Buy	30,232 +1,192	+4%	+$48.5K	0.08%	233
2016 Q3	$1.2M	Buy	29,040 +3,390	+13%	+$142K	0.09%	176
2016 Q2	$1.02M	Sell	25,650 -150	-0.6%	-$5.4K	0.08%	182
2016 Q1	$869K	Buy	25,800 +1,700	+7%	+$53K	0.06%	195
2015 Q4	$817	Sell	24,100 -950	-4%	-$29.7K	0.06%	206
2015 Q3	$746	Sell	25,050 -1,127	-4%	-$35.2K	0.06%	219
2015 Q2	$629	Hold	26,177	–	–	0.04%	248
2015 Q1	$629	Buy	26,177 +856	+3%	+$20.2K	0.04%	248
2014 Q4	$561K	Buy	+25,321	New	+$513K	0.04%	281

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First National Bank of Omaha's IART Position: Q3 2023 in Review

First National Bank of Omaha sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 35,445 shares — an estimated $1.46M sold.

First National Bank of Omaha first reported a position in IART in Q4 2014 and held it in 35 quarters. The position peaked at $3.76M in Q4 2020. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

First National Bank of Omaha reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
First National Bank of Omaha sold 35,445 Integra LifeSciences shares in Q3 2023, an estimated $1.46M.
First National Bank of Omaha first reported a position in Integra LifeSciences in Q4 2014 and held it in 35 quarters.
First National Bank of Omaha's Integra LifeSciences position peaked at $3.76M in Q4 2020.
262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on First National Bank of Omaha's 13F filing for Q3 2023, filed 14 Nov 2023.